Identification of a 13‑mRNA Signature for Predicting Disease Progression and Prognosis in Patients With Bladder Cancer

Oncology Reports - Greece
doi 10.3892/or.2019.7429
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Identification of Hub Genes Associated With Progression and Prognosis in Patients With Bladder Cancer

Frontiers in Genetics
GeneticsMolecular Medicine
2019English

Overexpression of Thymosin Β10 Correlates With Disease Progression and Poor Prognosis in Bladder Cancer

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2019English

An Immune Relevant Signature for Predicting Prognoses and Immunotherapeutic Responses in Patients With Muscle-Invasive Bladder Cancer (MIBC)

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2020English

Development of a 15-Gene Signature for Predicting Prognosis in Advanced Colorectal Cancer

Bioengineered
Applied MicrobiologyBiotechnologyMedicineBioengineering
2020English

ROR1 Expression as a Biomarker for Predicting Prognosis in Patients With Colorectal Cancer

Oncotarget
Oncology
2017English

A Panel of 13-miRNA Signature as a Potential Biomarker for Predicting Survival in Pancreatic Cancer

Oncotarget
Oncology
2016English

Identification of S100a8-Correlated Genes for Prediction of Disease Progression in Non-Muscle Invasive Bladder Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2010English

The Application of Artificial Intelligence to Microarray Data: Identification of a Novel Gene Signature to Identify Bladder Cancer Progression

European Urology
Urology
2010English

Identification of a Gene Signature Associated With Radiotherapy and Prognosis in Gliomas

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy